10835 ROAD TO THE CURE, SUITE 140, SAN DIEGO, CA
Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results
Other Events
Announces Pricing of Upsized Public Offering of Common Stock
Results of Operations and Financial Condition
Investor Presentation
Financial Results, Press Release
Submission of Matters to a Vote of Security Holders
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Correspondence
Submission Upload